[artículo] 
inJournal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 3 (Junio) . - pp. 317-324

Título :	Cannabinoid receptor 1 blocker rimonabant (sr 141716) for treatment of alcohol dependence : Results from a placebo-controlled, double-blind trial
Tipo de documento:	texto impreso
Autores:	Michael Soyka, Autor ; Gabriele Koller, Autor ; Peggy Schmidt, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 317-324
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Alcoholismo, Índice de masa corporal, Piperidinas, Pirazoles.
Resumen:	Multiple lines of evidence suggest that the endocannabinoid system is implicated in the development of alcohol dependence. In addition, in animal models, the cannabinoid receptor 1 blocker rimonabant was found to decrease alcohol consumption, possibly by indirect modulation of dopaminergic neurotransmission.
Link:	./index.php?lvl=notice_display&id=30853

[artículo] Cannabinoid receptor 1 blocker rimonabant (sr 141716) for treatment of alcohol dependence : Results from a placebo-controlled, double-blind trial [texto impreso] / Michael Soyka, Autor ; Gabriele Koller, Autor ; Peggy Schmidt, Autor . - 2023 . - pp. 317-324.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 3 (Junio) . - pp. 317-324

Palabras clave:	Alcoholismo, Índice de masa corporal, Piperidinas, Pirazoles.
Resumen:	Multiple lines of evidence suggest that the endocannabinoid system is implicated in the development of alcohol dependence. In addition, in animal models, the cannabinoid receptor 1 blocker rimonabant was found to decrease alcohol consumption, possibly by indirect modulation of dopaminergic neurotransmission.
Link:	./index.php?lvl=notice_display&id=30853